Observational studyBMC cancer2021

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.

Akiko Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.